First, we transfected synthetic single-stranded tsRNA targeting EGFR (tsEGFR) into BT549 breast cancer cells in parallel with commercially available double-stranded siRNA against EGFR (siEGFR) and measured the change of EGFR expression by qRT-PCR. The gene discussed is EGFR; the disease is breast cancer.